Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma

BACKGROUND: Patients with diffuse midline gliomas (DMGs), including diffuse intrinsic pontine glioma (DIPG), have dismal outcomes. We previously described the H3.3K27M mutation as a shared neoantigen in HLA-A*02.01(+), H3.3K27M(+) DMGs. Within the Pacific Pediatric Neuro-Oncology Consortium, we asse...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Invest
Main Authors: Mueller, Sabine, Taitt, Jared M., Villanueva-Meyer, Javier E., Bonner, Erin R., Nejo, Takahide, Lulla, Rishi R., Goldman, Stewart, Banerjee, Anu, Chi, Susan N., Whipple, Nicholas S., Crawford, John R., Gauvain, Karen, Nazemi, Kellie J., Watchmaker, Payal B., Almeida, Neil D., Okada, Kaori, Salazar, Andres M., Gilbert, Ryan D., Nazarian, Javad, Molinaro, Annette M., Butterfield, Lisa H., Prados, Michael D., Okada, Hideho
Format: Artigo
Language:Inglês
Published: American Society for Clinical Investigation 2020
Subjects:
Clinical Medicine
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685729/
https://ncbi.nlm.nih.gov/pubmed/32817593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI140378
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items